Altered expression of Nrf2-targeted genes is associated with AD, and previous studies have demonstrated that the activation of Nrf2 ameliorates Aβ pathology and cognitive deficits in AD mouse models (Bahn et al., 2019). The gene discussed is NFE2L2; the disease is Alzheimer disease.